197 related articles for article (PubMed ID: 22822073)
1. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
[TBL] [Abstract][Full Text] [Related]
2. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
4. Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging.
Macdonald-Obermann JL; Piwnica-Worms D; Pike LJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):137-42. PubMed ID: 22190492
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
[TBL] [Abstract][Full Text] [Related]
7. Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization.
Hughes JB; Berger C; Rødland MS; Hasmann M; Stang E; Madshus IH
Mol Cancer Ther; 2009 Jul; 8(7):1885-92. PubMed ID: 19584234
[TBL] [Abstract][Full Text] [Related]
8. Gangliosides influence EGFR/ErbB2 heterodimer stability but they do not modify EGF-dependent ErbB2 phosphorylation.
Milani S; Sottocornola E; Zava S; Galbiati M; Berra B; Colombo I
Biochim Biophys Acta; 2010 Jun; 1801(6):617-24. PubMed ID: 20156584
[TBL] [Abstract][Full Text] [Related]
9. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
Muthuswamy SK; Gilman M; Brugge JS
Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
[TBL] [Abstract][Full Text] [Related]
10. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
11. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.
Wang Z; Zhang L; Yeung TK; Chen X
Mol Biol Cell; 1999 May; 10(5):1621-36. PubMed ID: 10233167
[TBL] [Abstract][Full Text] [Related]
12. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
[TBL] [Abstract][Full Text] [Related]
13. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
[TBL] [Abstract][Full Text] [Related]
14. Intensification of growth factor receptor signalling by phorbol treatment of ligand-primed cells implies a dimer-stabilizing effect of protein kinase C-dependent juxtamembrane domain phosphorylation.
Gulliford T; Ouyang X; Epstein RJ
Cell Signal; 1999 Apr; 11(4):245-52. PubMed ID: 10372802
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 and ErbB3 receptors mediate inhibition of calcium-dependent chloride secretion in colonic epithelial cells.
Keely SJ; Barrett KE
J Biol Chem; 1999 Nov; 274(47):33449-54. PubMed ID: 10559227
[TBL] [Abstract][Full Text] [Related]
16. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.
Riese DJ; Komurasaki T; Plowman GD; Stern DF
J Biol Chem; 1998 May; 273(18):11288-94. PubMed ID: 9556621
[TBL] [Abstract][Full Text] [Related]
17. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
18. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.
Nagy P; Claus J; Jovin TM; Arndt-Jovin DJ
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16524-9. PubMed ID: 20813958
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
20. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
Liu Y; Li R; Ladisch S
J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
